25 Best Dividend Stocks to Buy According to Billionaires

8. Bristol-Myers Squibb Company (NYSE:BMY)

Number of Billionaire Investors: 17

Dividend Yield as of March 3: 4.16%

Bristol-Myers Squibb Company (NYSE:BMY) is an American pharmaceutical industry company. It continues to prioritize the development of new molecular entities while leveraging strategic acquisitions to strengthen its research and development capabilities. This strategy enhances its competitive edge, drives innovation, and reinforces its standing in the pharmaceutical industry. In the past 12 months, the stock has surged by over 17%.

In Q4 2024, Bristol-Myers Squibb Company (NYSE:BMY) reported $12.34 billion in revenue, marking a 7.5% increase from the previous year. Its Growth Portfolio delivered particularly strong results, with revenue rising 21% to $6.4 billion. This growth was fueled by high demand for key treatments such as Reblozyl, Breyanzi, and Camzyos, which saw annual sales surges of 71%, 125%, and 101%, respectively.

By the end of the year, Bristol-Myers Squibb Company (NYSE:BMY) held more than $10.3 billion in cash and cash equivalents. Recognized as one of the best dividend stocks, the company has maintained dividend payments for 93 years and has increased its payouts for 16 consecutive years. It offers a per-share dividend of $0.62 every quarter for a dividend yield of 4.16%, as of March 3.